NTCB02-1

NTCB02-1 · Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NTCB02-1, covering 2025-01-07 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition [Phase 3]

See pricing